Search by Drug Name or NDC

    NDC 72189-0259-32 CEFDINIR 250 mg/5mL Details

    CEFDINIR 250 mg/5mL

    CEFDINIR is a ORAL POWDER, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by DIRECT RX. The primary component is CEFDINIR.

    Product Information

    NDC 72189-0259
    Product ID 72189-259_cc1f06ae-3fc2-714c-e053-2995a90ac865
    Associated GPIs 02300040001930
    GCN Sequence Number 058005
    GCN Sequence Number Description cefdinir SUSP RECON 250 MG/5ML ORAL
    HIC3 W1Y
    HIC3 Description CEPHALOSPORIN ANTIBIOTICS - 3RD GENERATION
    GCN 23308
    HICL Sequence Number 018548
    HICL Sequence Number Description CEFDINIR
    Brand/Generic Generic
    Proprietary Name CEFDINIR
    Proprietary Name Suffix n/a
    Non-Proprietary Name CEFDINIR
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form POWDER, FOR SUSPENSION
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/5mL
    Substance Name CEFDINIR
    Labeler Name DIRECT RX
    Pharmaceutical Class Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210534
    Listing Certified Through 2024-12-31

    Package

    NDC 72189-0259-32 (72189025932)

    NDC Package Code 72189-259-32
    Billing NDC 72189025932
    Package 100 mL in 1 BOTTLE (72189-259-32)
    Marketing Start Date 2021-09-13
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 982d0f53-20bc-1cb4-e053-2995a90ad33c Details

    Revised: 9/2021